0001209191-22-046209.txt : 20220817 0001209191-22-046209.hdr.sgml : 20220817 20220817160145 ACCESSION NUMBER: 0001209191-22-046209 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220809 FILED AS OF DATE: 20220817 DATE AS OF CHANGE: 20220817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blavatnik Len CENTRAL INDEX KEY: 0001326628 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38067 FILM NUMBER: 221173927 MAIL ADDRESS: STREET 1: C/O ACCESS INDUSTRIES STREET 2: 730 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Access Industries Holdings LLC CENTRAL INDEX KEY: 0001391297 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38067 FILM NUMBER: 221173930 BUSINESS ADDRESS: STREET 1: C/O ACCESS INDUSTRIES MANAGEMENT, LLC. STREET 2: 730 FIFTH AVENUE, 20TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212 247 6400 MAIL ADDRESS: STREET 1: C/O ACCESS INDUSTRIES MANAGEMENT, LLC. STREET 2: 730 FIFTH AVENUE, 20TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AI Biotechnology LLC CENTRAL INDEX KEY: 0001942670 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38067 FILM NUMBER: 221173929 BUSINESS ADDRESS: STREET 1: C/O ACCESS INDUSTRIES, INC. STREET 2: 40 WEST 57TH STREET, 28TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-247-6400 MAIL ADDRESS: STREET 1: C/O ACCESS INDUSTRIES, INC. STREET 2: 40 WEST 57TH STREET, 28TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ACCESS INDUSTRIES MANAGEMENT, LLC CENTRAL INDEX KEY: 0001508226 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38067 FILM NUMBER: 221173928 BUSINESS ADDRESS: STREET 1: 730 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2122476400 MAIL ADDRESS: STREET 1: 730 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verona Pharma plc CENTRAL INDEX KEY: 0001657312 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE BUSINESS PHONE: 011-44-0-2032834200 MAIL ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2022-08-09 0 0001657312 Verona Pharma plc VRNA 0001391297 Access Industries Holdings LLC C/O ACCESS INDUSTRIES, INC. 40 WEST 57TH STREET, 28TH FLOOR NEW YORK NY 10019 0 0 1 0 0001942670 AI Biotechnology LLC C/O ACCESS INDUSTRIES, INC. 40 WEST 57TH STREET, 28TH FLOOR NEW YORK NY 10019 0 0 1 0 0001508226 ACCESS INDUSTRIES MANAGEMENT, LLC C/O ACCESS INDUSTRIES, INC. 40 WEST 57TH STREET, 28TH FLOOR NEW YORK NY 10019 0 0 1 0 0001326628 Blavatnik Len C/O ACCESS INDUSTRIES, INC. 40 WEST 57TH STREET, 28TH FLOOR NEW YORK NY 10019 0 0 1 0 Ordinary Shares 51111648 I By AI Biotechnology LLC The securities reported are held directly by AI Biotechnology LLC ("AIB") and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because Len Blavatnik controls AIM and controls a majority of the outstanding voting interests in AIH, AIM controls AIH, and AIH controls all of the outstanding voting interests in AIB. Each of the reporting persons (other than AIB) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form. Exhibit List: Ex.24 - Power of Attorney /s/ Alejandro Moreno for Access Industries Holdings LLC 2022-08-17 /s/ Alejandro Moreno for AI Biotechnology LLC 2022-08-17 /s/ Alejandro Moreno for Access Industries Management, LLC 2022-08-17 /s/ Alejandro Moreno as Attorney-in-Fact for Mr. Blavatnik 2022-08-17 EX-24 2 attachment1.htm EX-24 DOCUMENT
LIMTED POWER OF ATTORNEY


Know all by these presents, that the undersigned hereby constitutes and appoints
Lincoln Benet and Alejandro Moreno, and each of them individually, the
undersigned's true and lawful attorney-in-fact to:
	execute for and on behalf of the undersigned, in the undersigned's capacity as
a beneficial owner of Verona Pharma plc (the "Company"): (i) Forms 3, 4 and 5
and any other forms required to be filed in accordance with Section 16(a) of the
Securities Exchange Act of 1934 (the "Exchange Act") and the rules thereunder (a
"Section 16 Form"), (ii) all forms and schedules in accordance with Section
13(d) of the Exchange Act and the rules thereunder, including all amendments
thereto (a "Section 13 Schedule"), (iii) a Form ID Application, Passphrase
Update Application and/or request to convert from paper only to electronic filer
with the U.S. Securities and Exchange Commission and to obtain access codes to
file on EDGAR and any other forms required to be filed or submitted in
accordance with Regulation S-T promulgated by the United States Securities and
Exchange Commission (or any successor provision) in order to file a Section 13
Schedule or a Section 16 Form electronically (a "Form ID", and, together with a
Section 16 Form and a Section 13 Schedule, the "Forms and Schedules") and (iv)
any Joint Filing Agreement or similar agreement with respect to the filing of
any of the Forms or Schedules in (i) through (iii) above;
	do and perform any and all acts for and on behalf of the undersigned which may
be necessary or desirable to complete and execute any such Forms and Schedules,
complete and execute any amendments thereto, and timely file such Forms and
Schedules with the U.S. Securities and Exchange Commission and any stock
exchange or similar authority; and
	take any other action of any type whatsoever in connection with the foregoing
which, in the opinion of each such attorney-in-fact, may be of benefit to, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by each such attorney-in-fact on behalf
of the undersigned pursuant to this Limited Power of Attorney shall be in such
form and shall contain such terms and conditions as he may approve in his
discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that each such attorney-in-fact, or his
substitute or substitutes, shall lawfully do or cause to be done by virtue of
this Limited Power of Attorney and the rights and powers herein granted.
The undersigned acknowledges that each such attorney-in-fact is serving in such
capacity at the request of the undersigned, and is not assuming, nor is the
Company assuming, any of the undersigned's responsibilities to comply with
Section 13 or Section 16 of the Exchange Act.
This Limited Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file any Forms and Schedules with respect
to the undersigned's holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered
to each such attorney-in-fact.
From and after the date hereof, any Limited Power of Attorney previously granted
by the undersigned concerning the subject matter hereof is hereby revoked.
IN WITNESS WHEREOF, the undersigned has executed this Limited Power of Attorney
as of August 15, 2022.
LEONARD BLAVATNIK


/s/ Leonard Blavatnik